Zümrüt Arda Kaymak

Zümrüt Arda Kaymak

Auto-generated profile, based on publicly available information

Zümrüt Arda Kaymak

SÜLEYMAN DEMİREL ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, RADYASYON ONKOLOJİSİ ANABİLİM DALI

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2020 in The Clinical Respiratory Journal
Verified
Journal Article
Closed access
PDF file
EOEmine Elif Ozkan
Emine Elif Ozkan
ZCZumrut Arda Kaymak Cerkesli
Zumrut Arda Kaymak Cerkesli
MEMehmet Erdogan
Mehmet Erdogan

15 July 2014 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
TKTimur Koca
Timur Koca
HBHamit Başaran
Hamit Başaran
DADeniz Arslan
Deniz Arslan
DSDuygu Sezen
Duygu Sezen
ZÇZümrüt Arda Çerkeşli
Zümrüt Arda Çerkeşli
MDMünir Demirci
Münir Demirci
Ameloblastoma is a benign but locally aggressive tumor of odontogenic epithelial tissue. Reports of radiotherapy treatment modalities are limited in the literature.

1 January 2020 in Reports of Practical Oncology and Radiotherapy
Verified
Journal Article
Closed access
EOEmine Elif Ozkan
Emine Elif Ozkan
AOAlper Ozseven
Alper Ozseven
ZCZ. Arda Kaymak Cerkesli
Z. Arda Kaymak Cerkesli
To investigate the predictive value of convenience of rectum dosimetry with Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) dose limits, maximum rectum dose (Dmax), total rectal volume (TVrectum), rectal volume included in PTV (VrectumPTV) on Grade 2-3 acute rectal toxicity for utilization in clinical practice. Numerous previous data have reported frequent acute proctitis after external-beam RT of prostate cancer. Predicting toxicity limited with dose information is inadequate in clinical practice due to comorbidities and medications used. Sixty-four non-metastatic prostate cancer patients treated with IMRT were enrolled. Patients were treated to a total dose of 70-76 Gy. Rectal dose volume histograms (DVH) of all patients were evaluated retrospectively, and a QUANTEC Score between 0 and 5 was calculated for each patient. The correlation between the rectal DVH data, QUANTEC score, TVrectum, VrectumPTV, rectum Dmax and Grade 2-3 rectal toxicity was investigated. In the whole group grade 1, 2 and 3 acute rectal toxicities were 25%, 18.8% and 3.1%, respectively. In the DVH data, rectum doses of all patients were under RTOG dose limits. Statistically significant correlation was found between grade 2-3 rectal toxicity and TVrectum (p = 0,043); however. It was not correlated with QUANTEC score, VrectumPTV and Dmax. Our results were not able to show any significant correlation between increasing convenience with QUANTEC limits and lower rectal toxicity. Conclusively, new dosimetric definitions are warranted to predict acute rectal toxicity more accurately in prostate cancer patients during IMRT treatment.

1 June 2021 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
ZKZümrüt Arda Kaymak
Zümrüt Arda Kaymak
NKNermin Karahan
Nermin Karahan
MEMehmet Erdoğan
Mehmet Erdoğan
EEEvrim Erdemogľu
Evrim Erdemogľu
İZİsmail Zihni
İsmail Zihni
SŞSevim Süreyya Şengül
Sevim Süreyya Şengül
Objectives: Post-hypoxia hypoxia-inducible factor (HIF)-1 alpha activation plays a vital role in colorectal cancer (CRC) angiogenesis. Although glucose metabolism is induced in some cancer types via HIF-1 alpha, the prognostic significance of HIF-1 alpha in CRC and its correlation with 18-fluorinefluorodeoxyglucose (F-18-FDG) uptake in positron emission tomography (PET) remain controversial. This study aims to investigate the association between F-18-FDG/PET parameters and HIF-1 alpha expression in CRC. Methods: Thirty-six histopathologically confirmed patients with CRC who had F-18-FDG/PET scans before surgery were enrolled in the study. The correlations between the maximum standardized uptake value (SUVmax), SUVmean, metabolic tumor volume (MTV), total lesion glycolysis, HIF-1 alpha overexpression, and histopathological features were evaluated. Results: The tumor location, tumor diameter, perineural invasion, lymphovascular invasion, T and N stage were not significantly correlated with HIF-1 alpha overexpression. In contrast, the tumor differentiation was negatively correlated with HIF-1 alpha expression (r=-0.332, p=0.048). None of the F-18-FDG/PET parameters was significantly correlated with HIF-1 alpha overexpression. A significant relationship was found between tumor differentiation, tumor necrosis percentage, and MTV (p=0.030, p=0.020). Conclusion: The expected association between HIF-1 alpha overexpression and F-18-FDG/PET parameters was not found in this study. However, there was a relationship between MTV, tumor differentiation, and tumor necrosis percentage. Hence, further studies are required to predict the pathological and prognostic courses of CRC using a diagnostic F-18-FDG/PET evaluation.

21 June 2021 in Indian Journal of Cancer
Verified
Journal Article
Closed access
ZKZumrut Arda Kaymak
Zumrut Arda Kaymak
EOEmine Elif Ozkan
Emine Elif Ozkan
Background: Curative thoracic radiotherapy (CTRT) with concurrent chemotherapy has been considered as standard treatment approach for stage-III non-small cell lung cancer (NSCLC). The hematological and esophageal toxicities that have been encountered during CTRT would affect the immunonutritional status of the patients. The aim of this study is to evaluate the prognostic value of the change in pre- and post-treatment prognostic nutritional index (PNI) in stage-III NSCLC patients. Methods: Eighty seven consecutive stage III NSCLC patients’ data were collected. Pre-radiotherapy (RT) and post-RT PNI values were calculated and the impact of prognostic value of PNI change on overall survival (OS) was evaluated by univariate and multivariate Cox regression analyses. A cutoff value of PNI change was obtained by receiver operator characteristic (ROC) curve analysis. Results: The cutoff value was found to be a 22% decrease in PNI by ROC curve analysis in terms of effect on OS. The median OS of low and high PNI decrease groups were 22.5 and 16.5 months respectively (P = 0,001). In univariate and multivariate analyses PNI decrease of ≥ 22% was found to be an independent poor prognostic factor for OS (P = 0.012) and hazard ratio (95% confidence interval)= 2.05 (1.16–3.62). Conclusion: The PNI change would be a convenient parameter to assess the immunonutritional status of the patient at the end of CTRT. A decrease of more than 22% of PNI value may predict poor prognosis.

1 March 2023 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Closed access
GEGamze Erkilinc
Gamze Erkilinc
RYRamazan Oğuz Yüceer
Ramazan Oğuz Yüceer
EEEvrim Erdemogľu
Evrim Erdemogľu
ZKZümrüt Arda Kaymak
Zümrüt Arda Kaymak
ŞDŞerife Mehtap Darbaş
Şerife Mehtap Darbaş
MÇMetin ibrahim çiriş
Metin ibrahim çiriş
To evaluate the expression of stanniocalcin-1 (STC-1) and to investigate the correlation of STC-1 with expression of estrogen receptor (ER), progesterone receptor (PR) and clinical parameters, histopathological findings and prognostic factors in endometrioid endometrial cancer (EEC). In this retrospective study, STC-1 (cytoplasmic), ER (nuclear), and PR (nuclear) stainings were applied to tissue microarray sections of 89 EEC, 27 endometrial intraepithelial neoplasia (EIN), and 21 normal endometrium (NE). Prognostic factors such as age, tumor size, depth of myometrial invasion, lymphovascular invasion, perineural invasion, and lymph node metastasis were compared with the expression of these markers. ER showed significantly higher positivity in grade 1 EEC. PR expression was also higher in grade 1 EEC, but these findings were not statistically significant. Strong expression of STC-1 was observed in EIN and EECs compared with NE. STC-1 showed low staining in the NE, and high staining was also noted in the EIN foci adjacent to the NE. STC-1 expression was positively correlated with grade 1 EECs. STC-1 expression was positively correlated with low histologic grade in EECs. STC-1 can be used for distinguishing low-grade endometrioid tumors and high -grade endometrioid tumors in curretage specimens. Since STC-1 is related to well differentiated tumors, it can also be regarded as a good prognostic factor in EECs.